Aurora Spine Secures FDA Clearance for AERO Facet Fusion System

Aurora Spine ( (TSE:ASG) ) has shared an update.

Aurora Spine has received FDA 510(k) clearance for its AERO Facet Fusion System, a minimally invasive device designed for patients with facet joint-related pain or instability. The system, which can be used independently or alongside larger spinal fusion surgeries, is expected to begin initial surgeries in late Q3 2025. The AERO system is engineered to promote bone fusion while minimizing soft tissue disruption, aligning with Aurora Spine’s commitment to patient-first innovations. The clearance is seen as a significant milestone for the company, with expectations that the AERO system will drive growth and improve patient care in spinal surgery.

More about Aurora Spine

Aurora Spine is a company dedicated to introducing innovative solutions to the spinal implant market, focusing on proprietary, minimally invasive, and regenerative technologies. The company aims to enhance surgical outcomes through innovation, efficiency, and patient-centered design.

YTD Price Performance: -15.00%

Average Trading Volume: 38,681

Technical Sentiment Signal: Buy

Current Market Cap: C$24.71M

Find detailed analytics on ASG stock on TipRanks’ Stock Analysis page.